Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cell and Gene Therapy Manufacturing Services Market to reach USD 15630.64 million by 2027.

Global Cell and Gene Therapy Manufacturing Services Market is segmented by Type (Cell, Gene), Indication (Oncology, Cardiology, Orthopedic, Other), Mode (In-house, Contract), End-user Industry (Pharm & Biotechnology, Academic and Research Institute ),Regional Forecasts 2021-2027

Product Code: HLSHS-15106564
Publish Date: 20-09-2021
Page: 200

Global Cell and Gene Therapy Manufacturing Services Market is valued approximately at USD 7367.01 million in 2020 and is anticipated to grow with a healthy growth rate of more than 12.34% over the forecast period 2021-2027. The area of cell and gene therapy is revolutionizing way cancer patients and those with genetic disorders are treated. These new therapeutic possibilities enhance patient outcomes dramatically and, in some situations, are curative. However, manufacturing of such medicines poses complex new challenges. The cost of manufacture remains a significant barrier to clinical translation and commercialization of these potentially game-changing medicines today. To manufacture high-quality medications in a reliable and cost-effective manner, new technologies are required. While patients will benefit from new treatment options, the risks for patients and drug developers are high. The market is driven by the key factors such as Increasing investments of pharmaceutical companies in the Research & Development and Increase in the number of chronic diseases, orthopaedic and other cardiovascular diseases. major pharma firms are boosting their R&D efficiency by investing heavily in R&D, in order to ensure long returns on investments, as well as by collaborating with the R&D centres worldwide. for instance: According to Statista, Roche is expected to be the world’s largest company which is investing heavily in R&D, that is, USD 14 Billion followed by Johnson & Johnson (USD 12.2 Billion), Merck & Co (USD 11.4 Billion), Pfizer (USD 10.5 Billion) and Novartis (USD 10 Billion), by the year 2026. However, increasing in the operational costs, may impede market growth over the forecast period of 2021-2027.

Geographically, North America is Dominating the market shares of Cell and gene therapy manufacturing services market owing to rising strategic steps taken by private players and growing number of cancer cases in the region. Furthermore, United States market consists of many prominent players in cell and gene therapy manufacturing services, which are taking strategic steps such as technological advancements, mergers and others to develop new solutions for gene and cell therapy. However, APAC is estimated to be the fastest growing region due to growing development in research and development in cell and gene therapy. Also, China is expected to grow with the highest growth rate during forecast period, due to rising number of approvals by government authorities and growing industrialization of cell and gene therapy in the region

Major market player included in this report are:
Thermo fisher Scientific Inc.
Merck KGaA
Charles River Laboratories
Lonza
Catalent, Inc.
Takara Bio Inc.
Fujifilm Holdings Corporation
Roche Ltd
Wuxi Advanced Therapies
Cell and Gene Therapy Catapult

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Types of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Cell
Gene
By Indication:
Oncology
Cardiology
Orthopedic
Other
By Mode:
In house
Contract
By End user:
Pharma and Biotechnology companies
Academic and research Institute
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Cell and Gene Therapy Manufacturing Services Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
1.2.1. Cell and Gene therapy Manufacturing Services Market, by region, 2019-2027 (USD Million)
1.2.2. Cell and Gene therapy Manufacturing Services Market, by Type, 2019-2027 (USD Million)
1.2.3. Cell and Gene therapy Manufacturing Services Market, by Indication, 2019-2027 (USD Million)
1.2.4. Cell and Gene therapy Manufacturing Services Market, by Mode, 2019-2027 (USD Million)
1.2.5. Cell and Gene therapy Manufacturing Services Market, by End user, 2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell and Gene therapy Manufacturing Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell and Gene therapy Manufacturing Services Market Dynamics
3.1. Cell and Gene therapy Manufacturing Services Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing investments of pharmaceutical companies in the Research & Development
3.1.1.2. Increase in the number of chronic diseases, orthopaedics and other cardiovascular diseases
3.1.2. Market Restraint
3.1.2.1. increasing in the operational costs
3.1.3. Market Opportunities
3.1.3.1. increase in the number of clinical therapies for cell and gene therapies
Chapter 4. Global Cell and Gene therapy Manufacturing Services Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell and Gene therapy Manufacturing Services Market, by Type
5.1. Market Snapshot
5.2. Global Cell and Gene therapy Manufacturing Services Market by Type, Performance – Potential Analysis
5.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Million)
5.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
5.4.1. Cell
5.4.2. Gene
Chapter 6. Global Cell and Gene therapy Manufacturing Services Market, by Indication
6.1. Market Snapshot
6.2. Global Cell and Gene therapy Manufacturing Services Market by Indication, Performance – Potential Analysis
6.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Million)
6.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Cardiology
6.4.3. Orthopaedic
6.4.4. Others
Chapter 7. Global Cell and Gene therapy Manufacturing Services Market, by Mode
7.1. Market Snapshot
7.2. Global Cell and Gene therapy Manufacturing Services Market by Mode, Performance – Potential Analysis
7.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Mode 2018-2027 (USD Million)
7.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
7.4.1. In house manufacturing
7.4.2. Contract manufacturing
Chapter 8. Global Cell and Gene therapy Manufacturing Services Market, by End user industry
8.1. Market Snapshot
8.2. Global Cell and Gene therapy Manufacturing Services Market by End user industry, Performance – Potential Analysis
8.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by End user industry 2018-2027 (USD Million)
8.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Biotechnology companies
8.4.2. Academic and research institute
Chapter 9. Global Cell and Gene therapy Manufacturing Services Market, Regional Analysis
9.1. Cell and Gene therapy Manufacturing Services Market, Regional Market Snapshot
9.2. North America Cell and Gene therapy Manufacturing Services Market
9.2.1. U.S. Cell and Gene therapy Manufacturing Services Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. Mode breakdown estimates & forecasts, 2018-2027
9.2.1.4. End User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell and Gene therapy Manufacturing Services Market
9.3. Europe Cell and Gene therapy Manufacturing Services Market Snapshot
9.3.1. U.K. Cell and Gene therapy Manufacturing Services Market
9.3.2. Germany Cell and Gene therapy Manufacturing Services Market
9.3.3. France Cell and Gene therapy Manufacturing Services Market
9.3.4. Spain Cell and Gene therapy Manufacturing Services Market
9.3.5. Italy Cell and Gene therapy Manufacturing Services Market
9.3.6. Rest of Europe Cell and Gene therapy Manufacturing Services Market
9.4. Asia-Pacific Cell and Gene therapy Manufacturing Services Market Snapshot
9.4.1. China Cell and Gene therapy Manufacturing Services Market
9.4.2. India Cell and Gene therapy Manufacturing Services Market
9.4.3. Japan Cell and Gene therapy Manufacturing Services Market
9.4.4. Australia Cell and Gene therapy Manufacturing Services Market
9.4.5. South Korea Cell and Gene therapy Manufacturing Services Market
9.4.6. Rest of Asia Pacific Cell and Gene therapy Manufacturing Services Market
9.5. Latin America Cell and Gene therapy Manufacturing Services Market Snapshot
9.5.1. Brazil Cell and Gene therapy Manufacturing Services Market
9.5.2. Mexico Cell and Gene therapy Manufacturing Services Market
9.6. Rest of The World Cell and Gene therapy Manufacturing Services Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo fisher Scientific Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Charles River Laboratories
10.2.4. Lonza
10.2.5. Catalent, Inc.
10.2.6. Takara Bio Inc.
10.2.7. Fujifilm Holdings Corporation
10.2.8. Roche Ltd
10.2.9. Wuxi Advanced Therapies
10.2.10. Cell and Gene Therapy Catapult
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now